Drug
Xp19986
Xp19986: highest development phase Phase 2, developed by Indivior. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Indivior
Trials
| Drug | Phase | Indication |
|---|---|---|
| XP19986 CR NCT00838396 | Phase 2 | GERD |
Latest
No recent events.
Follow Xp19986 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.